INS and Insulin resistance: The comparisons between SGLT2i treatment with other glucose-lowering agents on the indices of insulin resistance (fasting insulin, HOMA-IR, CPR, adipo-IR), beta-cell function (CPR index, HOMA-B), systolic and diastolic blood pressure (SBP), diastolic blood pressure (DBP), non-esterified fatty acids (NEFA) and low-density lipoprotein (LDL) levels were non-significant.